Preparing your space
Preparing your space
Physical Wellness · ScienceDaily Chronic Illness · October 13, 2026

The FDA has approved the first drug that directly targets Alexander disease, a devastating neurological disorder affecting fewer than one in a million people. Developed through decades of research, Zanvastro showed promising results in clinical trials, stabilizing motor function and even improving movement in some patients.
Originally published by ScienceDaily Chronic Illness. We curate and add context; they did the reporting.
Read the full story at ScienceDaily Chronic Illness ↗